News Summary

Teal Health, backed by investors including Serena Ventures and Chelsea Clinton, has secured FDA approval for its Teal Wand, a device that allows individuals to screen for cervical cancer at home. The innovative device enables patients to self-collect samples and mail them to a lab for testing, similar to a pap smear conducted in a medical setting. This approval follows Teal Health’s $10 million seed extension round, bringing its total funding to $23 million. The device aims to reduce the intimidation associated with cervical cancer screenings, which are crucial for women’s health. The Teal Wand Kit, available starting in June in California, includes the collection device and virtual consultations with medical providers for result analysis.